NDT Pharmaceuticals, Inc.’s (OTC: NDTP) wholly-owned subsidiary Good Salt Life, Inc., a pioneer in innovative surface ...
Subject enrollment expected to begin in Q1 2026CDI-988 is the first oral broad-spectrum antiviral drug candidate for ...
Takeda Pharmaceutical Co. announced that its oral psoriasis drug zasocitinib proved safe and effective in late-stage trials, ...
Atossa Therapeutics, Inc. (Nasdaq: ATOS) ("Atossa" or the "Company"), a clinical-stage biopharmaceutical company developing novel therapies in oncology and other areas of high unmet clinical need, ...
RANCHO CUCAMONGA, CA / ACCESS Newswire / December 15, 2025 / Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) announced that the ...
Learn more about whether Catalyst Pharmaceuticals, Inc. or Nurix Therapeutics, Inc. is a better investment based on AAII's A+ ...
The global Vaginal Inserts Market is entering a transformative phase, projected to grow from USD 1.9 billion in 2025 to USD 3.2 billion by 2035, advancing at a steady CAGR of 5.2%. This sustained ...
At our Pharma & Health Insider Summit in the Poconos, leaders from Sanofi, Pfizer, Takeda, Endo Pharmaceuticals, and Organon shared insights on streamlining the patient journey through AI-powered ...
Amylyx Pharmaceuticals Presents New Exploratory Analyses from Phase 2 and Phase 2b Clinical Trials of Avexitide in Post-Bariatric Hypoglycemia at ENDO 2025 - Pivotal Phase 3 LUCIDITY trial of ...
Crinetics Pharmaceuticals, Inc. announced that eight abstracts detailing their clinical development programs will be presented at the Endocrine Society's Annual Meeting, ENDO 2025. The presentations ...
JACKSBORO, Tenn. — The district attorneys general of Tennessee’s Sixth, Seventh, Eighth, Ninth and Tenth Judicial Districts have jointly filed a lawsuit against prescription opioid manufacturer Purdue ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback